Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women
Open Access
- 6 October 2006
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 6 (1) , 239
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Androgen receptor polymorphisms and endometrial cancer riskInternational Journal of Cancer, 2005
- Gender, smoking, glutathione--transferase variants and bladder cancer incidence: a population-based studyCancer Letters, 2005
- Genetic variability in susceptibility and response to toxicantsToxicology Letters, 2001
- Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studiesInternational Journal of Cancer, 2000
- Arylaminc N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among JapanesePharmacogenetics, 1999
- Epidemiology and etiology of bladder cancerSeminars in Surgical Oncology, 1997
- Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesisToxicology Letters, 1995
- The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part ICritical Reviews in Biochemistry and Molecular Biology, 1995
- Distribution of Ethylene Oxide in Human Blood and its Implications for BiomonitoringHuman & Experimental Toxicology, 1991
- Acetylator genotype and arylamine-induced carcinogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1988